Western Sky Medical Research
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Employees
- -
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 4:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 4
2 (100.0%)Fluticasone Furoate Treatment of Daytime Somnolence and Cognitive Performance in Seasonal Allergic Rhinitis
Phase 4
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-10-19
- Last Posted Date
- 2018-05-18
- Lead Sponsor
- Western Sky Medical Research
- Target Recruit Count
- 40
- Registration Number
- NCT00997620
Comparing Bronchodilation of Symbicort With and Without Valved Holding Chamber (Aerochamber Plus)
Phase 4
Completed
- Conditions
- Asthma
- Interventions
- Drug: pMDI budesonide/formotrol 160/4.5 is in group 1Device: Symbicort 160/4.5 plus Aerochamber Plus included in group 2
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2020-08-13
- Lead Sponsor
- Western Sky Medical Research
- Target Recruit Count
- 16
- Registration Number
- NCT00915538
- Locations
- 🇺🇸
Western Sky Medical Research, El Paso, Texas, United States
News
No news found